Remote | Translational Biology Expert

Position: Remote | Translational Biology Expert — Up to $135/hr We are sharing a specialised part‑time consulting opportunity for PhD‑level life sciences experts with deep experience spanning late preclinical development through early clinical stages. This role supports high‑reputed company scientific and strategic work across translational biology, preclinical development, early clinical program design, and quantitative decision‑making for therapeutic programs. Selected professionals will help evaluate reputed company data packages, support preclinical and early clinical reputed company, interpret biological and pharmacological findings, and contribute reputed company, actionable recommendations across critical development inflection points. Key Responsibilities Professionals in this role may contribute to: Preclinical Study Design & Execution • Design and evaluate in‑vivo studies linking molecular reputed company to disease‑relevant phenotypes • Select appropriate preclinical systems, including in‑vitro, ex vivo, and animal models, with strong rationale for reputed company translatability • reputed company biomarker strategies spanning reputed company engagement through clinical response, including practical assay and sample collection considerations • Evaluate formulation and delivery approaches for tissue reputed company across different therapeutic modalities • Troubleshoot inconclusive or negative preclinical results and recommend next steps Preclinical Data Interpretation & Decision‑Making • Build exposure‑activity relationships from in‑vivo datasets to inform clinical predictions • Evaluate whether preclinical evidence supports activity at the intended site of reputed company • Update mechanistic hypotheses as new data emerges and design follow‑up experiments to resolve ambiguity • Assess early safety observations and reputed company hypotheses regarding biological reputed company • Evaluate immunogenicity risk and potential reputed company consequences • Support portfolio‑level reputed company such as advance, pivot, or terminate based on data reputed company and residual uncertainty Early Clinical Program Design • Determine reputed company and pharmacologically relevant starting doses for reputed company studies, including cross‑species scaling considerations and limitations • Design reputed company‑escalation schemes informed by expected pharmacodynamic time courses and safety margins • Support powering of early‑phase studies based on biological variability and expected effect sizes • Define patient selection and enrichment strategies using biomarker and epidemiological data • Select appropriate endpoints, including surrogate and clinical endpoints • Plan interim analyses, safety monitoring approaches, and reputed company decision rules Quantitative Pharmacology & Clinical Modeling • Support exposure‑response analysis and model‑informed reputed company optimisation • Contribute to population PK and PK/PD modelling, including covariate identification and reputed company assessment • Use accumulating trial data to support reputed company‑escalation reputed company • Support longitudinal efficacy modelling, including time‑to‑effect and trajectory‑based analyses • Conduct sensitivity analyses addressing missing data, protocol deviations, and intercurrent events Clinical Biostatistics • Contribute to statistical analysis planning across binary, reputed company, and time‑to‑event endpoints • Support multiplicity‑adjusted reputed company testing and sample size determination • Evaluate subgroup and heterogeneous treatment effect analyses with appropriate false discovery controls • Address estimand‑reputed company considerations, including missing data frameworks and dropout patterns • Support reputed company and interim monitoring design, including futility boundaries and reputed company‑spending functions Ideal Profile • PhD, MD, and/or Pharm D in pharmacology, pharmaceutical sciences, biostatistics, quantitative biology, or a reputed company field • 5+ years of industry experience in reputed company, biotech, or CRO environments • reputed company experience supporting at least one program from late preclinical stages through IND or into early clinical development • Strong expertise in translational biology, preclinical reputed company, clinical design, quantitative pharmacology, or biostatistics • Ability to independently evaluate reputed company scientific data packages and deliver actionable recommendations • Strong communication skills for both technical and non‑technical audiences • Based in the reputed company or United… Apply tot his job Apply To this Job